Post Profile

Novo Nordisk to ax 1,000 jobs in cost-cutting drive

COPENHAGEN (Reuters) - The world's largest insulin maker, Novo Nordisk, is cutting 1,000 jobs as a part of a plan to reduce costs as it faces a challenging environment in 2017, especially in the large U.S. market, the company said on Thursday.
read more


Related Posts

Boeing to cut commercial airplane jobs to reduce costs

Business & Finance : Business Insider: Clusterstock

SEATTLE (Reuters) - Boeing Co said on Wednesday it will cut jobs at its commercial airplane unit as part of an ongoing effort to reduce costs. The company, the world's biggest aircraft maker, said it would begin making cuts with man...

Lars Rebien Sorensen, CEO of Novo Nordisk | The Tough Business of Caring -

Medical / Pharmaceutical : PharmaGossip

By JEANNE WHALEN When cash-strapped Greece last year told Danish drug maker Novo Nordisk A/S it planned to cut the prices it paid for certain insulins by more than a quarter in an effort to slash its spending, Lars Rebien Sorensen, ...

Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent

Health : Reuters: Health

COPENHAGEN (Reuters) - Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent according to the keenly awaited results of a clinical trial released on Friday.

Novo Nordisk now says it accepts new Greek insulin prices | Reuters

Medical / Pharmaceutical : PharmaGossip

UPDATE 2-Novo Nordisk says accepts new Greek insulin prices | Reuters COPENHAGEN, June 14 (Reuters) - Denmark's Novo Nordisk ( NOVOb.CO ), the world's biggest maker of insulin, said on Monday it would resume supplies of its modern i...

Novo Nordisk CEO Lars Rebien Sorensen to step down by end-2016

Health : Reuters: Health

COPENHAGEN (Reuters) - Lars Rebien Sorensen, chief executive of the world's largest insulin maker Novo Nordisk, will step down by the end of 2016 after 16 years in the job, the Danish company said on Thursday.


Copyright © 2016 Regator, LLC